Nine-year prospective efficacy and safety of brain-responsive #neurostimulation for focal #epilepsy
Prospectively evaluate safety and efficacy of brain-responsive neurostimulation in adults with medically intractable focal onset seizures (FOS) over 9 years.. Adults treated with brain-responsive neurostimulation within 2 year feasibility or randomized controlled trials enrolled into a long-term prospective open label trial (LTT) to assess safety, efficacy, and quality of life (QOL) over an additional 7 years. Safety was assessed as adverse events (AEs), efficacy as … Continue reading Nine-year prospective efficacy and safety of brain-responsive #neurostimulation for focal #epilepsy